Two 'hot' #BSTPath cases to warm up your weekend! N°1: 45yF, thigh mass, deep located. Your differentials? Any IHCs? A. Polónia @caseypschukow Sumanta Das Anandi Lobo, MD Aleksandr Romanov M.hossein shahidi Olaleke Folaranmi SANO Naoki, MD, Pathologist, Japan Sumeyra Kartal Nishat Afroz MD #PathTwitter #pathresidents

Mesmerizing urate crystals river 😲❤️

Twitter me this… 🔹Large sinonasal mass. 🔹H&Es attached.

A special #BSTPath hat trick, same IHC but different diagnoses, N°1: old F, trunk dermal lesion, your thoughts? A. Polónia Sumanta Das Sumeyra Kartal SANO Naoki, MD, Pathologist, Japan Rehdam (Madiha) Olaleke Folaranmi Şeyma Büyücek Charles Lépine, MD Luiz M. Nova-Camacho, MD Nishat Afroz MD Greg Charville Barry McGinn #PathTwitter

Three different #BSTPath entities and the same IHC marker, are you able to tell me which diagnoses and which shared IHC? A. Polónia Barry McGinn SANO Naoki, MD, Pathologist, Japan Sumeyra Kartal @caseypschukow Charles Lépine, MD Rehdam (Madiha) zigic krikic 🔻Nusrat Zahra🔻🇵🇸 Kashif M M, MD, FRCPath idlewild #PathTwitter Case N°1:

Let's go to case N°2, here the IHC to guess is expressed only focally A. Polónia Barry McGinn SANO Naoki, MD, Pathologist, Japan Sumeyra Kartal @caseypschukow Charles Lépine, MD Rehdam (Madiha) zigic krikic 🔻Nusrat Zahra🔻🇵🇸 Kashif M M, MD, FRCPath idlewild Venkatesh Dhanasekaran Bonita Borah🌼 #pathology #PathTwitter #BSTPath

And finally Case N°3, a classic in #BSTPath #DermPath with this I wish you a great WeekEnd! A. Polónia Barry McGinn SANO Naoki, MD, Pathologist, Japan Sumeyra Kartal @caseypschukow Charles Lépine, MD Rehdam (Madiha) zigic krikic 🔻Nusrat Zahra🔻🇵🇸 Kashif M M, MD, FRCPath idlewild Venkatesh Dhanasekaran #pathology #PathTwitter

🔬 La Société Française de Pathologie et les Annales de Pathologie s'associent pour l'édition 2023 du concours photo 📸 ⏳ Vous avez jusqu'au 1e octobre pour y participer! 👉 Toutes les infos sont ici buff.ly/3D0qBGa #pathart #pathology #francophonepath Société Française de Pathologie

Excellent symposium SFCC/SFP glandes salivaires Carrefour Pathologie 2023 #Milan2 classification OMS Apport de la bio mol Charles Lépine Valérie Costes-Martineau Claude Bigorgne Emmanuelle Uro-Coste 👏🏻👍🏻

I’m gonna give 10 random people that repost this and follow me $25,000 for fun (the $250,000 my X video made) I’ll pick the winners in 72 hours

incentivized testnet final phase loading… ███████████████] 99% sign up now👇 deform.plumenetwork.xyz/testnet/

❌GCT of bone: adults, oval mononuclear cells (not spindled like NOF), giant cell nuclei ~ mononuclear cell nuclei that are (+) H3.3 G34W ❌ Fibrous dysplasia: well-demarcated ground glass lesion; irregular trabeculae in background of bland spindle cells ✅Non-ossifying fibroma:

Bone lesion. Your diagnosis? Answer here: kikoxp.com/posts/4499 Sanjay Mukhopadhyay Radiopaedia.org #BSTpath #radpathmatch #radiology #sarcoma #pathologists #pathology #pathTwitter

Clear cell metaplasia in a sigmoid polyp from my colleague Amy Leeming. Resembles secretory endometrium and perhaps Sertoli cells! No clinical importance but pretty! Nice review by Dabir, van der Post & Nagtegaal. Histopathology, 2021. 78: 348-357 #GIpath #Pathologists Pathkids.com

████████████████ 100% all goons can now board, enter here 👇 miles.plumenetwork.xyz

Trained on 1.5 million WSIs from 100,000 patients, a pathology foundation model is shown to improve performance of specialized models in detection of rare cancers Paige Microsoft Research #DigitalPathology #FoundationModel Thomas J. Fuchs nature.com/articles/s4159…

We're excited to announce our $15M Series A led by Founders Fund to build the Metalayer, the end game for Ethereum rollups 🌋 This round brings our total funding to $25M and will help us advance our goal of making Ethereum go web-scale.

CD28 co-stimulation: novel insights and applications in cancer immunotherapy dlvr.it/TB4Ksg

Identification 🤓of Resistance Biomarkers to HER2 Inhibitors: Advances and Challenges in HER2+ Breast Cancer 🔴Therapeutic advances: HER2 inhibitors have significantly improved the treatment of HER2+ breast cancer. 🟢Persistent challenge: Resistance to these drugs remains a

As many of you now may be aware, Dr. Chris Fletcher recently passed away. His contributions to the field of ST pathology (and my career) are immeasurable. Interestingly, once I decided in 1993 to develop expertise in #BSTpath, my question was where (or with whom) would I train?